Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
GAVE
MCID: GST020
MIFTS: 41

Gastric Antral Vascular Ectasia (GAVE)

Categories: Blood diseases, Cardiovascular diseases, Gastrointestinal diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Gastric Antral Vascular Ectasia

About this section

MalaCards integrated aliases for Gastric Antral Vascular Ectasia:

Name: Gastric Antral Vascular Ectasia 12 52 43 15 17
Watermelon Stomach 12 74 52
Gave 52

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Cardiovascular diseases Gastrointestinal diseases Blood diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:2493
MeSH 43 D020252
NCIt 49 C84724
SNOMED-CT 67 43935004
UMLS 71 C0267211
Sources

Summaries for Gastric Antral Vascular Ectasia

About this section
NIH Rare Diseases : 52 Watermelon stomach is a condition in which the lining of the stomach bleeds, causing it to look like the characteristic stripes of a watermelon when viewed by endoscopy . Although it can develop in men and women of all ages, watermelon stomach is most commonly observed in older women (over age 70 years). Signs and symptoms of watermelon stomach include blood in the stool , hematemesis (vomiting blood) and anemia . The exact cause of watermelon stomach is unknown; however, it is often diagnosed in people with other chronic (long-term) conditions such as cirrhosis (scarring of the liver and poor liver function), autoimmune disease , systemic sclerosis , and CREST syndrome . Treatment consists of surgery and/or medications to stop or control the bleeding.

MalaCards based summary : Gastric Antral Vascular Ectasia, also known as watermelon stomach, is related to active peptic ulcer disease and esophageal varix. An important gene associated with Gastric Antral Vascular Ectasia is MIR3677 (MicroRNA 3677), and among its related pathways/superpathways are Salivary secretion and Secretion of Hydrochloric Acid in Parietal Cells. The drugs Guaifenesin and Acetylcholine have been mentioned in the context of this disorder. Affiliated tissues include liver, heart and testes.

Wikipedia : 74 Gastric antral vascular ectasia (GAVE) is an uncommon cause of chronic gastrointestinal bleeding or iron... more...

Sources

Related Diseases for Gastric Antral Vascular Ectasia

About this section

Diseases related to Gastric Antral Vascular Ectasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 315)
# Related Disease Score Top Affiliating Genes
1 active peptic ulcer disease 31.3 SST ATP4A ATP12A
2 esophageal varix 30.9 SST ATP4A ATP12A
3 angiodysplasia 30.7 SST ATP4A ATP12A
4 gastritis 30.6 SST GAST ATP4A
5 crest syndrome 30.2 TOP1 CENPS
6 diffuse scleroderma 30.1 TOP1 OXCT1
7 telangiectasis 29.9 TOP1 CENPS
8 pernicious anemia 29.7 SST GAST ATP4A ATP12A
9 gastroesophageal reflux 29.6 GAST ATP4A ATP12A
10 stomach disease 29.3 SST GAST ATP4A ATP12A
11 transcobalamin ii deficiency 11.3
12 hyperlipidemia, familial combined, 3 11.1
13 marfan syndrome 11.1
14 pseudo-von willebrand disease 11.1
15 spherocytosis, type 1 11.1
16 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1 11.1
17 smith-lemli-opitz syndrome 11.1
18 ichthyosis, x-linked 11.1
19 sacral defect with anterior meningocele 11.1
20 agammaglobulinemia 1, autosomal recessive 11.1
21 ehlers-danlos syndrome 11.1
22 iron metabolism disease 11.0
23 deficiency anemia 11.0
24 iron deficiency anemia 10.9
25 scleroderma, familial progressive 10.9
26 portal hypertension 10.8
27 liver cirrhosis 10.8
28 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.6
29 systemic scleroderma 10.6
30 autoimmune disease 10.6
31 varicose veins 10.6
32 primary biliary cirrhosis 10.5
33 connective tissue disease 10.4
34 end stage renal disease 10.4
35 liver disease 10.4
36 atrophic gastritis 10.4
37 vagus nerve disease 10.3 ATP4A ATP12A
38 hemangioma of intra-abdominal structure 10.3 ATP4A ATP12A
39 acquired gastric outlet stenosis 10.3 ATP4A ATP12A
40 angiodysplasia of intestine 10.3 ATP4A ATP12A
41 benzylpenicillin allergy 10.3 ATP4A ATP12A
42 penicillin allergy 10.3 ATP4A ATP12A
43 bacterial esophagitis 10.3 ATP4A ATP12A
44 lingual goiter 10.3 ATP4A ATP12A
45 cascade stomach 10.3 ATP4A ATP12A
46 gastrojejunal ulcer 10.3 ATP4A ATP12A
47 median arcuate ligament syndrome 10.3 ATP4A ATP12A
48 laryngeal tuberculosis 10.3 ATP4A ATP12A
49 fungal esophagitis 10.3 ATP4A ATP12A
50 dieulafoy lesion 10.3 ATP4A ATP12A

Graphical network of the top 20 diseases related to Gastric Antral Vascular Ectasia:



Diseases related to Gastric Antral Vascular Ectasia
Sources

Symptoms & Phenotypes for Gastric Antral Vascular Ectasia

About this section
Sources

Drugs & Therapeutics for Gastric Antral Vascular Ectasia

About this section

Drugs for Gastric Antral Vascular Ectasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 643)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
2
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
3
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
4
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
5
Peginterferon alfa-2a Approved, Investigational Phase 4 198153-51-4 5360545
6
Adenosine Approved, Investigational Phase 4 58-61-7 60961
7
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
8
Hydrocodone Approved, Illicit, Investigational Phase 4 125-29-1 5284569
9
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
10
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
11
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
12
Metformin Approved Phase 4 657-24-9 14219 4091
13
Zinc Approved, Investigational Phase 4 7440-66-6 32051
14
Misoprostol Approved Phase 4 59122-46-2 5282381
15
Histamine Approved, Investigational Phase 4 51-45-6 774
16
Acetaminophen Approved Phase 4 103-90-2 1983
17
Remifentanil Approved Phase 4 132875-61-7 60815
18
tannic acid Approved Phase 4 1401-55-4
19
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
20 Lycopene Approved, Investigational Phase 4 502-65-8 53477748
21
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 5311068 68602
22
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
23
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
24
Sargramostim Approved, Investigational Phase 4 83869-56-1, 123774-72-1
25
Lenograstim Approved, Investigational Phase 4 135968-09-1
26
Empagliflozin Approved Phase 4 864070-44-0
27
Iodine Approved, Investigational Phase 4 7553-56-2 807
28
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
29
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
30
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
31
Digoxin Approved Phase 4 20830-75-5 30322 2724385
32
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
33
Racepinephrine Approved Phase 4 329-65-7 838
34
Vortioxetine Approved, Investigational Phase 4 508233-74-7 9966051
35
Sertraline Approved Phase 4 79617-96-2 68617
36
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
37
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
38
Leuprolide Approved, Investigational Phase 4 53714-56-0 657181 3911
39 sodium fluoride Approved Phase 4 7681-49-4
40
carbamide peroxide Approved Phase 4 124-43-6
41
Povidone-iodine Approved Phase 4 25655-41-8
42
Loperamide Approved Phase 4 53179-11-6 3955
43
Azithromycin Approved Phase 4 83905-01-5 447043 55185
44
Ethanol Approved Phase 4 64-17-5 702
45
Everolimus Approved Phase 4 159351-69-6 70789204 6442177
46
Valproic acid Approved, Investigational Phase 4 99-66-1 3121
47
Quinapril Approved, Investigational Phase 4 85441-61-8 54892
48
Repaglinide Approved, Investigational Phase 4 135062-02-1 65981
49
Dulaglutide Approved, Investigational Phase 4 923950-08-7
50
Insulin aspart Approved Phase 4 116094-23-6 16132418

Interventional clinical trials:

(show top 50) (show all 883)
# Name Status NCT ID Phase Drugs
1 The Use of Toxin Botulinum A Toxin in Patients With Parkinson's Disease and Multiple System Disease, Affected by Refractory Detrusor Overactivity. Unknown status NCT00822913 Phase 4 Intravesical injection of Botulinum A toxin
2 Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State Unknown status NCT01338623 Phase 4 Tansulosine
3 The Changes of CD8+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B Unknown status NCT03209037 Phase 4 Peginterferon Alfa-2a
4 The Changes of CD4+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B Unknown status NCT03209011 Phase 4 Peginterferon Alfa-2a
5 The Changes of Natural Killer Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B. Unknown status NCT03208998 Phase 4 Peginterferon Alfa-2a
6 The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels .A Prospective Randomized Controlled Trial. Unknown status NCT02602301 Phase 4 Oxytocin
7 Effect of Bispectral Index (BIS) Monitoring on Faster Recovery Time and Analgesic Consumption in Abdominal Surgery Patients Unknown status NCT01470898 Phase 4
8 Evaluation Whether Higher Retention Rate is in Those of Combined Methadone With N-Acetyl-Cysteine Compared to Those With Methadone Alone During a Six-month Study Unknown status NCT01047956 Phase 4 Methadone; NAC;Methadone
9 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis: a Randomized, Investigator-blinded Study Unknown status NCT01439425 Phase 4
10 The Effect of Maternal Antenatal Steroid Administration on the Blood Flow Through the Pulmonary Artery in the Term Fetus; a Randomized Control Double Blinded Study Unknown status NCT02978976 Phase 4 Betamethasone;saline
11 Post-tonsillectomy Pain Control in Adults: a Randomized Prospective Study Unknown status NCT02358850 Phase 4 Norco (Hydrocodone and Acetaminophen);Percocet (Oxycodone and Acetaminophen);Dilaudid (hydromorphone);Tylenol (Acetaminophen)
12 A Developmental Clinical Study of Management Guided by Coronary Angiography Combined With Fractional Flow Reserve (FFR) Measurement Versus Management Guided by Coronary Angiography Alone(Standard Care) in Patients With Non-ST Elevation MI. Unknown status NCT01764334 Phase 4
13 Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines Completed NCT04412044 Phase 4 Mepolizumab Injection [Nucala]
14 A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery Completed NCT02113150 Phase 4 remifentanil;Ketamine
15 Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes Completed NCT00470158 Phase 4
16 Bone Remodeling Around HA-coated Acetabular Cups. Completed NCT00159497 Phase 4
17 Systemic Lycopene as an Adjunct to Scaling and Rootplaning in Chronic Periodontitis Patients With Type 2 Diabetes Mellitus Completed NCT02263352 Phase 4 Lycored soft gels Jagsonpal Pharma, Systemic 8mgms/day
18 Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration. Completed NCT02067117 Phase 4 GC FLU® Injection, GC FLU® Pre-filled Syringe Injection
19 Effects of Vitamin D Supplements on Pregnancy Outcomes in Embriyo Transfer Cycles Completed NCT03890458 Phase 4 DEVIT-3
20 Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood Completed NCT02839902 Phase 4 TAK-085
21 Pharmacokinetics of Metformin Intolerance Completed NCT03361878 Phase 4 Metformin Hydrochloride
22 Anti-anginal and Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina:A Phase III, Multicentre, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg Administered Orally Once Daily) Compared to Placebo in Type 2 Diabetes Mellitus Patients With Refractory Angina(EMPT-ANGIN TRIAL) Completed NCT04143321 Phase 4 Empagliflozin 25 MG
23 Blood Levels of Neurosteroids and Neurotrophic Factors in Normal Controls and in Patients With Major Depression Completed NCT00812994 Phase 4 Escitalopram;Placebo
24 Effects of Early Parenteral Iron Combined Erythropoietin in Preterm Infants Completed NCT02060851 Phase 4 Vifor;Vifor and EPO
25 The Impact of Different Doses of Vitamin A Supplementation on Male and Female Childhood Morbidity and Mortality Completed NCT00168636 Phase 4 Vitamin A
26 A Randomized, Double-blind Clinical Trial of Two Inactivated Hepatitis A Vaccines in Healthy Children Completed NCT01252680 Phase 4
27 Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia in Patients Undergoing Thoracotomy During Anesthesia Recovery Period Completed NCT01517932 Phase 4 dexmedetomidine;saline placebo
28 Long-term Follow-up at 10 Years of Patients Enrolled in the Fingolimod Phase II Program in Relapsing Multiple Sclerosis (MS) Completed NCT02307838 Phase 4
29 Vortioxetine Versus Sertraline in Control Metabolic, Distress and Depression in Mexican Patients With Type 2 Diabetes Completed NCT03978286 Phase 4 Vortioxetine;Sertraline
30 A Randomized, Double-blind, Active Control, 3-parallel Group, Forced Titration, Multicenter, Phase IV Study to Evaluate the Efficacy and Safety of Fimasartan Versus Valsartan Monotherapy in Patients With Mild to Moderate Essential Hypertension Completed NCT02495324 Phase 4 Placebo;Fimasartan;Valsartan;Olmesartan medoxomil
31 Effectiveness of Nebulized Hypertonic Saline and Epinephrine in Hospitalized Infants With Bronchiolitis Completed NCT01300325 Phase 4
32 Randomized, Cross-over Trial With Metformin in Women With Polycystic Ovary Syndrome Completed NCT02280057 Phase 4 Metformin;Placebo
33 A Multicenter, Open, Prospective Study to Evaluate the Safety and Efficacy of Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty Completed NCT03316482 Phase 4 Leuplin DPS 11.25mg
34 Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome, A Pilot Study Completed NCT02731300 Phase 4
35 Controlled Trial in Women With Recurrent Miscarriage of G-CSF Versus Placebo Completed NCT00772122 Phase 4 G-CSF;saline solution
36 Loperamide Plus Azithromycin More Effectively Treats Travelers' Diarrhea In Mexico Than Azithromycin Alone Completed NCT00359970 Phase 4 Azithromycin 500 mg;Azithromycin 1000 mg;Loperamide
37 Safety, Acceptability and Efficacy of a Silica Dentifrice Containing Blue Pigment on Tooth Whitening: a Randomized Clinical Trial Completed NCT02741427 Phase 4
38 Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor: Randomized Clinical Trial Completed NCT02732522 Phase 4 Sublingual misoprostol;Vaginal misoprostol
39 The Ischemia Management With Accupril Post Bypass Graft Via Inhibition of the coNverting Enzyme (IMAGINE) Trial Completed NCT00269243 Phase 4 Quinapril
40 Comparison of Digoxin and Ivabradine in Heart Failure With Preserved Systolic Function. Time to Rethink About Digoxin. Completed NCT01699776 Phase 4 Ivabradine;Digoxin
41 Comparison of Outcomes of Two Approaches in Microsurgical Varicocelectomy in Chinese Infertile Males: A Prospective Randomized, Controlled Trial Completed NCT01463787 Phase 4
42 Arterial Stiffness and Endothelial Function Indexes, Relationships With Clinical and Laboratory Variables in a Group of Diabetic Patients in Treatment With Dulaglutide: a Case-control Study Completed NCT03824002 Phase 4 Dulaglutide;Aspart insulin;Glargine;Metformin;Repaglinide
43 Absorption of Orally Ingested Phosphate in Head and Neck Cancer Patients With and Without Refeeding Syndrome Completed NCT02880072 Phase 4
44 Potential Biomarkers for Atherosclerosis in Type 2 Diabetic Patients Maintained on Statin Therapy Completed NCT03784703 Phase 4 Atorvastatin (Atrostat®, Delta Pharmaceutical Industries, Cairo, Egypt) tablets.;Rosuvastatin (Rosuvastatin Calcium®, Chemipharm Co.
45 Comparison of Three Different Anesthetic Approaches for Intravitreal Injections: A Prospective Randomized Trial Completed NCT02263690 Phase 4
46 A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain: A Randomized Control Trial Completed NCT03221946 Phase 4 Diclofenac Sodium;Diclofenac sodium;Diclofenac
47 Comparative Electrocardiographic Effects of Intravenous Ondansetron and Granisetron in Patients Undergoing Surgery for Carcinoma Breast: A Prospective Single Blind Randomised Trial Completed NCT01352130 Phase 4 Ondansetron;Granisetron
48 Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution Alone and In Combination on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen. Completed NCT01007253 Phase 4 PL nasal spray;fluticasone furoate (FF);PL eye drops;olopatadine (OLO)
49 Role of Empiric Anti-reflux Therapy in Pediatric Otitis Media With Effusion - a Pilot Study Completed NCT01082029 Phase 4 Lansoprazole;Placebo
50 Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients With Dry Eye Due to Systemic Isotretinoin Therapy Completed NCT02752763 Phase 4 %40 diluted Autologous serum;Preservative free artificial tears(Tears naturale free, Refresh single dose eye drop)

Search NIH Clinical Center for Gastric Antral Vascular Ectasia

Cochrane evidence based reviews: gastric antral vascular ectasia

Sources

Genetic Tests for Gastric Antral Vascular Ectasia

About this section
Sources

Anatomical Context for Gastric Antral Vascular Ectasia

About this section

MalaCards organs/tissues related to Gastric Antral Vascular Ectasia:

40
Liver, Heart, Testes, Bone, Brain, Breast, T Cells
Sources

Publications for Gastric Antral Vascular Ectasia

About this section

Articles related to Gastric Antral Vascular Ectasia:

(show top 50) (show all 462)
# Title Authors PMID Year
1
Portal Hypertension and Chronic Kidney Disease Significantly Increase the Risk of Early Unplanned Readmissions in GAVE- Related Admissions. 61
32530981 2020
2
The cost-effectiveness of radiofrequency ablation for treating patients with gastric antral vascular ectasia refractory to first line endoscopic therapy. 61
32212980 2020
3
Magnifying endoscopy with narrow-band image for diagnosing diffuse type of gastric antral vascular ectasia in cirrhotic patients. 61
32433425 2020
4
Gastric antral vascular ectasia diagnosed in a 22-year-old patient. 61
32345578 2020
5
Successful banding of nodular gastric antral vascular ectasia in patients with refractory anemia. 61
32289332 2020
6
Diagnosis and Management of Gastric Antral Vascular Ectasia: Experience in a Large Single Cohort of Patients With Systemic Sclerosis. 61
32073520 2020
7
Intravenous Bevacizumab Reduces Transfusion Requirements and Endoscopic Interventions in Patients With Gastric Antral Vascular Ectasia and Small Bowel Angioectasia. 61
31759060 2020
8
Gastric antral vascular ectasia (GAVE) and hereditary hemorrhagic telangiectasia (HHT): two different conditions, one treatment. 61
31773212 2020
9
Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. 61
32266280 2020
10
'Watermelon stomach' as a presenting manifestation of systemic sclerosis. 61
31323093 2019
11
Severe gastrointestinal hemorrhage related to everolimus: a case report. 61
30955165 2019
12
Gastric Antral Vascular Ectasia Refractory to Endoscopic Treatment. 61
31812265 2019
13
Is endoscopic band ligation the gold standard for gastric antral vascular ectasia? 61
31790084 2019
14
Long-term follow-up in patients with gastric antral vascular ectasia (GAVE) after treatment with endoscopic band ligation (EBL). 61
31788543 2019
15
Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease. 61
31777820 2019
16
Comparative Effectiveness and Safety of Radiofrequency Ablation Versus Argon Plasma Coagulation for Treatment of Gastric Antral Vascular Ectasia: A Systematic Review and Meta-Analysis. 61
29952856 2019
17
Gastric antral vascular ectasia in portal hypertensive children: Endoscopic band ligation versus argon plasma coagulation. 61
30119927 2019
18
Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma. 61
30974480 2019
19
Response of authors to the comment on 'mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia'. 61
31165646 2019
20
Laparoscopic subtotal gastrectomy with Roux-en-Y reconstruction for long-term anticoagulation in gastric antral vascular ectasia syndrome. 61
31138599 2019
21
Comment on "Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE)". 61
31095437 2019
22
Gastric Antral Vascular Ectasia Causing Refractory Anemia in a Patient With Systemic Sclerosis. 61
31107696 2019
23
Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia. 61
31080606 2019
24
Predictors of blood transfusion and in-hospital outcomes in patients with gastric antral vascular ectasia (GAVE): a nationwide population-based analysis. 61
30906750 2019
25
Intravenous Cyclophosphamide for Gastric Antral Vascular Ectasia Associated with Systemic Sclerosis Refractory to Endoscopic Treatment: A Case Report and Review of the Pertinent Literature. 61
30101944 2019
26
Histologic and Endoscopic Similarity between Nodular Gastric Antral Vascular Ectasia and Gastric Hyperplastic Polyps Potentially Causing Treatment Delays. 61
31662762 2019
27
[A case of gastric antral vascular ectasia improved by splenorenal shunt embolization]. 61
31597880 2019
28
Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE). 61
30621516 2018
29
Features of multiple self-healing squamous epithelioma and Loeys-Dietz syndrome in a patient with a novel TGFBR1 variant. 61
30513140 2018
30
Diagnosis and Management of Gastric Antral Vascular Ectasia: Experience in a Large Single Cohort of Patients With Systemic Sclerosis. 61
30431488 2018
31
Angiosarcoma with Synchronous Cutaneous and Small Bowel Involvement: A Report of a Rare Presentation. 61
30723649 2018
32
Nitrous oxide cryotherapy ablation for refractory gastric antral vascular ectasia. 61
30288277 2018
33
Gastric Antral Vascular Ectasia Pathogenesis and the Link to the Metabolic Syndrome. 61
29961911 2018
34
New Indications for Endoscopic Radiofrequency Ablation. 61
29081376 2018
35
The Role of Therapeutic Endoscopy in Patients With Cirrhosis-Related Causes of Gastrointestinal Bleeding. 61
29886513 2018
36
[Diagnostic and therapeutic approach to Gastric antral vascular ectasia (GAVE): A case report and review of the literature]. 61
29663241 2018
37
An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia. 61
29450749 2018
38
Radiofrequency ablation (RFA) vs. argon plasma coagulation (APC) for the management of gastric antral vascular ectasia (GAVE) in patients with and without cirrhosis: results from a retrospective analysis of a large cohort of patients treated at a single center. 61
29497685 2018
39
Gastric Antral Vascular Ectasia: A Case Report and Literature Review. 61
29607305 2018
40
Gastric antral vascular ectasia presenting as a polypoid mass in a patient with cirrhosis. 61
28803743 2018
41
Case series on multimodal endoscopic therapy for gastric antral vascular ectasia, a tertiary center experience. 61
29375739 2018
42
HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature. 61
29721346 2018
43
[Systemic sclerosis in 2017]. 61
29595279 2018
44
Insights into the management of gastric antral vascular ectasia (watermelon stomach). 61
29399041 2018
45
Gastric antral vascular ectasia should not be overlooked in erythropoietin resistance: a series of case reports. 61
31308827 2018
46
Gastric antral vascular ectasia in systemic sclerosis: Where do we stand? 61
28217887 2017
47
Upper gastrointestinal bleeding (watermelon stomach) in a patient with limited scleroderma (CREST syndrome). 61
27353193 2017
48
Gastric Antral Vascular Ectasia and Metabolic Syndrome: Is There a Case for an Association? 61
29073974 2017
49
Nitrous oxide CryoBalloon therapy of refractory gastric antral vascular ectasia. 61
28679138 2017
50
An update on biomarker discovery and use in systemic sclerosis. 61
28730919 2017
Sources

Variations for Gastric Antral Vascular Ectasia

About this section
Sources

Expression for Gastric Antral Vascular Ectasia

About this section
Search GEO for disease gene expression data for Gastric Antral Vascular Ectasia.
Sources

Pathways for Gastric Antral Vascular Ectasia

About this section

Pathways related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Salivary secretion 36
Show member pathways
 11.35 SST GAST ATP4A
2
Secretion of Hydrochloric Acid in Parietal Cells 1
9.32 GAST ATP4A
Sources

GO Terms for Gastric Antral Vascular Ectasia

About this section

Biological processes related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 potassium ion import across plasma membrane GO:1990573 9.32 ATP4A ATP12A
2 cellular sodium ion homeostasis GO:0006883 9.26 ATP4A ATP12A
3 sodium ion export across plasma membrane GO:0036376 9.16 ATP4A ATP12A
4 cellular potassium ion homeostasis GO:0030007 8.96 ATP4A ATP12A
5 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 8.62 ATP4A ATP12A

Molecular functions related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP4A ATP12A
2 potassium-transporting ATPase activity GO:0008556 8.96 ATP4A ATP12A
3 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A
Sources

Sources for Gastric Antral Vascular Ectasia

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....